全球化学品在线数据库
| 产品名称 | CAS 登录号 | 分子式 |
|---|---|---|
| 那拉曲坦N-氧化物 | 1159977-52-2 | C17H25N3O3S |
| Naldecon | 83097-12-5 | C61H80Cl3N5O15 |
| 钠连二硫酸盐 | 14970-71-9 | Na2O6S2 |
| 钠磷酸氟化物 | 39456-59-2 | FH3NaO4P |
| 钠硫代苯甲酰基乙烷磺酸酯 | 117845-84-8 | C9H9NaO4S2 |
| 钠硫代苯甲酰基乙烷磺酸酯-d4 | 1189657-00-8 | C9H5D4NaO4S2 |
| 钠硫代锑酸盐(V)-9-水合物 | 10101-91-4 | H18Na3O9S4Sb |
| 钠硫代乙酸盐 | 34832-35-4 | C2H3NaOS |
| 钠六氟砷酸盐(V) | 12005-86-6 | AsF6Na |
| 钠六氟锡酸盐(IV) | 16924-51-9 | F6Na2Sn |
| 钠六氯钯酸盐(2-)水合物(2:1:1) | 16010-02-9 | H2Cl6Na2OPd |
| 钠六氯铂酸酯(2-)水合物(2:1:6) | 1307-82-0 | H12Cl6Na2O6Pt |
| 钠六氯铱酸盐(3-)水合物(3:1:1) | 123334-23-6 | H2Cl6IrNa3O |
| 钠硫酸丙酯盐 | 1000-56-2 | C3H7NaO4S |
| 钠硫酸丁酯盐 | 1000-67-5 | C4H9NaO4S |
| 钠硫酸十二烷基酯盐 | 556-76-3 | |
| 钠离子通道 I | 61183-76-4 | C36H71N3O6 |
| 钠离子通道 III | 81686-22-8 | C34H52N2O4 |
| Nalmexonum | 16676-26-9 | C21H25NO4 |
| Naloxazine | 71786-91-9 | C19H25N3O3 |
| Naloxegol | 854601-70-0 | C34H53NO11 |
| Naloxegol oxalate | 1354744-91-4 | C34H53NO11.C2H2O4 |
| 钠L-鼠李酮酸盐 | 159929-82-5 | C6H12NaO6 |
| Naltrexonazine | 82823-99-2 | C40H46N4O6 |
| 钠氯(氟)乙酸酯 | 70395-35-6 | C2HClFNaO2 |
| 6alpha-纳洛醇 | 20410-95-1 | C19H23NO4 |
| 6beta-纳洛醇 | 53154-12-4 | C19H23NO3 |
| 纳洛芬 | 62-67-9 | C19H22ClNO3 |
| 纳洛芬-7,8-氧化物 | 97242-25-6 | C19H21NO4 |
| 纳洛芬氢溴酸盐 | 1041-90-3 | C20H24BrNO3 |
| 纳洛肼二盐酸盐 | 82824-01-9 | C38H42N4O6 |
| 纳洛肼二盐酸盐 | 880759-65-9 | C38H42N4O6.2(HCl) |
| 那罗帕西 | 120819-70-7 | C19H17NO4S2 |
| 纳洛酮 | 465-65-6 | C19H21NO4 |
| 纳洛酮 EP 杂质 B | 1352085-46-1 | C22H25NO4 |
| 纳洛酮 EP 杂质 G | 70866-64-7 | C20H23NO4 |
| 纳洛酮-3,14-二乙酸酯 | 50510-01-5 | C23H26NO6 |
| 纳洛酮苯甲酰腙 | 119630-94-3 | C26H27N3O4 |
| 纳洛酮-d5 | 1261079-38-2 | C19H16D5NO4 |
| 纳洛酮N-氧化物溴化物 | 112242-14-5 | C19H21NO5 |
| 钠铝四氟化物 | 13821-15-3 | AlF4Na |
| 纳美芬 | 55096-26-9 | C21H25NO3 |
| 纳美酮盐酸盐 | 16676-27-0 | C21H26ClNO4 |
| NAMI-A | 201653-76-1 | |
| 那米罗汀 | 101506-83-6 | C17H18O2S |
| 那明特罗 | 93047-40-6 | C19H26N2O3 |
| 纳米氧化铁注射剂 | 722492-56-0 | |
| 钠咪唑并[1,2-a]吡啶-2-羧酸酯水合物(1:1:1) | 910036-83-8 | C8H7N2NaO3 |
| 纳莫雷特 | 1234-71-5 | C21H29NO3 |
| 钠M酮酸酯A | 66290-00-4 | C17H27NaO7 |